CAS No. 208466-51-7

L-Glutamic acid, L-histidyl-L-arginylglycylglycyl-L-prolyl-L-a-glutamyl-

Product Code: 2066890
Product Name: L-Glutamic acid, L-histidyl-L-arginylglycylglycyl-L-prolyl-L-a-glutamyl-
CAS Number: 208466-51-7
Molecular Formula: C31H48N12O12

Safety Data

Product Category

Order [ 208466-51-7 ] Now

About L-Glutamic acid, L-histidyl-L-arginylglycylglycyl-L-prolyl-L-a-glutamyl-

L-Glutamic acid, L-histidyl-L-arginylglycylglycyl-L-prolyl-L-a-glutamyl- is a chemical compound registered under CAS number 208466-51-7, with the molecular formula C31H48N12O12 and a molecular weight of about 780.8 g/mol. ChemicalsProvider supplies L-Glutamic acid, L-histidyl-L-arginylglycylglycyl-L-prolyl-L-a-glutamyl- for laboratory research and bulk production; product code 2066890. Send an inquiry for purity, packaging, price and lead time.

CAS Number: 208466-51-7
Molecular Formula: C31H48N12O12
Molecular Weight: 780.8 g/mol

Related Keywords

prolyl

glutamic

histidyl

glutamyl

arginylglycylglycyl

Glutamic

2,4-Thiazolidinedione,5-[5-(4-chlorophenyl)-4-pentynyl]-5-[(5-chloro-2-thienyl)sulfonyl]-

1-Propanone,1-[4-(3-mercaptopropoxy)phenyl]-2-methyl-2-(4-morpholinyl)-

2,5,8,11,14,17,20-Heptaoxapentatriacontan-35-oic acid

3,4-Thiophenedicarboxylic acid, tetrahydro-, 1,1-dioxide

2,5(1H,3H)-Quinazolinedione,4,6,7,8-tetrahydro-4-(2-methoxyphenyl)-7,7-dimethyl-, (4S)-

2,5(1H,3H)-Quinazolinedione,4-(4-bromophenyl)-4,6,7,8-tetrahydro-7,7-dimethyl-, (4S)-

484676-82-6

2,4-Tridecadien-1-one, 5-fluoro-1-phenyl-, (2E,4E)-

2,5(1H,3H)-Quinazolinedione,4-(3-chlorophenyl)-4,6,7,8-tetrahydro-1,7,7-trimethyl-, (4R)-

2,5(1H,3H)-Quinazolinedione,4-(2-bromophenyl)-4,6,7,8-tetrahydro-7,7-dimethyl-, (4R)-

2,5,8,11-Tetraoxatridecan-13-ol, 3,5-dinitrobenzoate

2,5,7-Trioxa-10-azaundecan-11-oic acid,9-[3-[5-[(1S)-1-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxoethyl]-3-methoxy-2-methylphenoxy]-4-methoxyphenyl]-, 2-(trimethylsilyl)ethyl ester,(9S)-

2,5,8-Nonatriynal, 4,7-dimethoxy-4,7-diphenyl-

801287-72-9

1-Propanone,1-[3-[1-hydroxy-2-methyl-1-(1-methylethyl)propyl]phenyl]-2-methyl-

2,5(1H,3H)-Quinazolinedione,4,6,7,8-tetrahydro-4-(2-methoxyphenyl)-7,7-dimethyl-, (4R)-

1-Propen-1-aminium, 3-ethoxy-N,N,N,2-tetramethyl-3-oxo-, bromide

1-Propanone,1-[6-(2-chlorophenyl)-5-(4-chlorophenyl)-3-(2-pyridinylamino)furo[2,3-b]pyridin-2-yl]-2,2-dimethyl-

2,5,8,11,14,17-Hexaoxa-19-azapentacosan-25-oic acid,18-oxo-16-(2,5,8,11,14-pentaoxapentadec-1-yl)-

2,4-Undecadiene-8,10-diynamide, N-(2-methylpropyl)-, (2E,4E)-

13891-74-2

7-Isoquinolinecarboxamide,2-[(3,4-difluorophenyl)methyl]-1,2-dihydro-1-oxo-N-(5-pyrimidinylmethyl)-

2,5,8,11,14-Cyclopentadecapentayne-1,7-diol,4,10,13-trimethoxy-1,4,7-tris(4-methoxyphenyl)-10,13-diphenyl-

1-Naphthalenecarboxamide, N-methoxy-N-methyl-3-nitro-

1-Propanone,1-[8-(dimethylamino)-5-quinolinyl]-2,2-difluoro-3-hydroxy-3-(3-pyridinyl)-

2,5(1H,3H)-Quinazolinedione,4-(2-bromophenyl)-4,6,7,8-tetrahydro-1,7,7-trimethyl-, (4R)-

2,5,8,11,14,17,20,23,26,29-Decaoxatetracontan-40-oic acid

873109-89-8

2,5,8,9-Tetraaza-1-phosphabicyclo[3.3.3]undecane,1,1-dihydro-2,8,9-trimethyl-1-[3-[[(4-methylphenyl)sulfinyl]oxy]-2-triazenylidene]-

2,4-Thiazolidinedione,5-[5-(4-chloro-2-methylphenyl)-4-pentynyl]-5-[(4-iodophenyl)sulfonyl]-

1-Propanone,1-[7-hydroxy-10-(4-hydroxyphenyl)-5-methyl-2-phenanthrenyl]-2-methyl-

2,5,8,11,14,17,20,23-Octaoxahentriacontan-31-oic acid, ethyl ester

1-Propanone,2,3-dibromo-3-(3,4-dimethoxyphenyl)-1-(3,4,5-trimethoxyphenyl)-

1-Propanone,2-[2-methoxy-4-(1E)-1-propenylphenoxy]-1-(3,4,5-trimethoxyphenyl)-,(2R)-

658706-64-0

2-Pyridinecarboxamide,4-[[2-[(4-bromophenyl)amino]-1-methyl-1H-benzimidazol-5-yl]oxy]-N-[2-(4-methoxyphenyl)ethyl]-

2,5,8,11-Tetraoxaheptacosan-27-oic acid

1H-1,2,4-Triazole, 5-(4-bromophenyl)-1-(4-nitrophenyl)-

2,5(1H,3H)-Quinazolinedione,4,6,7,8-tetrahydro-4-(3-methoxyphenyl)-1,7,7-trimethyl-, (4R)-

1-Propanone,2-[2,6-dimethoxy-4-(1E)-1-propenylphenoxy]-1-(3,4,5-trimethoxyphenyl)-, (2R)-

1-Propen-2-ol, 3,3,3-trichloro-, methanesulfonate